Loading clinical trials...
Loading clinical trials...
Investigation of the Side Effects of Orally Administered Glucocorticoids. An Open Label Study to Investigate the Effects of Orally Administered Prednisolone on Bone Metabolism in Patients With COPD.
The aim of this study is to establish associations between blood and urine markers of bone metabolism with histomorphometric changes (changes in the actual bone structure) resulting from short term oral prednisolone treatment in patients with COPD (chronic obstructive pulmonary disease).
Age
40 - 75 years
Sex
ALL
Healthy Volunteers
No
GSK Clinical Trials Call Centre
Cambridge, United Kingdom
Start Date
June 1, 2004
Primary Completion Date
January 1, 2006
Completion Date
January 1, 2006
Last Updated
April 16, 2015
9
ACTUAL participants
prednisolone
DRUG
Lead Sponsor
GlaxoSmithKline
Collaborators
NCT07477600
NCT05878769
NCT06717659
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions